Prostate cancer patient information.Takeshi ChiyomaruSoichiro YamamuraMohd Saif ZamanShahana MajidGuoren DengVarahram ShahryariSharanjot SainiHiroshi HirataKoji UenoInik Chang
Regarding information on self-help groups, rehabilitation options and a second medical opinion, there were significant differences between prostate cancer patient age groups: patients aged over 75 years old received less information on these aspects at all points in time.Patients at all ages feel ...
PHEN is a prostate cancer patient education and advocacy organization founded in 2003 to with a mission to eliminate the African American prostate cancer disparity and to support the needs of all men. PHEN Website PHEN Network Join survivors and caregivers in the fight against prostate cancer. ...
This resource provides expert advice about prostate cancer to help you discuss key issues with your healthcare provider. Learn the facts about risk factors, symptoms, screening, diagnosis, and treatment through easy-to-understand animations, expert video
A new study reports the 5-year patient-reported outcome data from a population-based cohort of men with localized prostate cancer. These findings in conjunction with data on survival, treatment burden and treatment cost can assist clinicians in explaining to newly diagnosed patients the likely ...
et al. The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro. Sci. Rep. 9, 4761 (2019). Article PubMed PubMed Central CAS Google Scholar Tian, X.-H. et al. XAV939, a tankyrase ...
It's always important first, basically [to] be able to establish whether the patient has organ-confined disease or not organ-confined disease. One of the changes that we have seen in the last year, year and a half, is the change in how you do a staging workup. In the past, CT bon...
The AmericanCancerSociety recommends a discussion between the doctor and patient about the pros and cons of PSA tests. Men shouldn't get the test unless their doctor has given them this information, the group says. It also recommends that the discussion start at age 50 for most men at averag...
prostate cancer management. They were confident that patients would not be discharged from secondary care untilurologyand/or oncology were happy with the patient's progress, they were assured of a quick referral route, and satisfied with the treatment and advice they provided. Some GPs felt self-...
Preclinical testing is a crucial step in evaluating cancer therapeutics. We aimed to establish a significant resource of patient-derived xenografts (PDXs) of prostate cancer for rapid and systematic evaluation of candidate therapies. The PDX collection comprises 59 tumors collected from 30 patients betwe...